Navigation Links
Bird flu -- Call for antiviral drugs to be shared

New predictions about bird flu, involving the use of a mathematical model, suggest that international cooperation to share antiviral drugs might be the best way to deal with an emerging pandemic.

'Bird flu'(avian H5N1 influenza) has not triggered a worldwide human epidemic yet because it rarely passes between people. If it does acquire this ability, it would take 6-8 months to develop a vaccine effective against the new virus. Public health officials therefore need to consider how they would protect people during the first few months of a pandemic. Measures might include the use of antiviral drugs and international travel restrictions. In a new study published in PLoS Medicine, researchers use detailed information on air travel to model the global spread of an emerging influenza pandemic and its containment. They conclude that much will depend on the 'reproductive number' (a measure of how many people an infectious individual infects on average) of the new virus that emerges. If this number is low, it will take many months before the virus spreads w orldwide and there will be plenty of time to bring an effective vaccine into use. But if the number is high then it could be difficult or impossible to contain the virus with vaccination.

Other measures could therefore be crucial, but it is likely that only a few countries will be able to stockpile supplies of drugs active against the virus. In these circumstances, compared with a 'selfish strategy' in which countries use their antiviral drugs only within their borders, limited worldwide sharing of antiviral drugs would slow down the spread of a flu virus by many months, to the benefit of both drug donors and recipients.
'"/>

Source:Public Library of Science


Page: 1

Related biology news :

1. Novel antiviral technology inhibits RSV infection in mice
2. Biota makes major antiviral discovery
3. New possibilities for flu antiviral and vaccine research emerge from Spanish flu virus
4. The reason why antiviral therapy cant annihilate HIV infection, and what to do about it
5. Molecular machine may lead to new drugs to combat human diseases
6. Researchers identify target for cancer drugs
7. MetaChip provides quick, efficient toxicity screening of potential drugs
8. Newly discovered pathway might help in design of cancer drugs
9. UNC launches study of liver injury caused by drugs
10. Findings have implications for tracking disease, drugs at the molecular level
11. Future diabetes drugs may target new protein interaction
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... Irvine, ca (PRWEB) , ... October 12, 2017 ... ... for the Surgical Wound Market with the addition of its newest module, US ... the $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalind™, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
Breaking Biology Technology: